Innovator Embraces Psychedelic Horizons With New Schedule 1 Manufacturing License
A new player is entering the psychedelics production space.
Compass’ Psilocybin Therapy Proves Helpful In Treating Anorexia: Clinical Trial Shows
UC-San Diego authors assessed psilocybin therapy’s potential as a treatment for anorexia nervosa.
They recently shared what are believed to be the first results from such a research study, and the findings look promising.
Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials
Cybin One Steps Away From Complete Dosing
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa’s Magic Pitch & More
Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People'
Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal prosecution for possession, use, purchase, cultivation and engaging in practices with “entheogenic plants or plant compounds."
Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds
GMP Drug Inc., a wholly-owned subsidiary of Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN: A3CSSU) has entered into a non-binding letter of intent with Zollaris Laboratories Corporation, an arms-length party, in pursuit of a potential transaction involvin
Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety
Enveric Biosciences (NASDAQ: ENVB) announced successful completion of preclinical absorption, distribution, metabolism, and excretion (ADME) and toxicology studies conforming to earlier positive results fro
A Quantum Leap In Psychedelic Research: Study Shows Real-Time Brain Changes After Ketamine Use
A newly published study shows that Kernel’s Flow technology system is in fact able to capture and analyze brain changes following the administration of a psychoactive substance.
Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy’s Garden And More
GOP-Controlled House Committee Blocks All Cannabis & Psychedelics Amendments To Defense Bill: Now, No Floor Vote
Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
Canadian clinical-stage natural psychedelics company Filament Health (OTCQB: FLHLF) has entered into a definitive agreement with Jupiter Acquisition Corp. (NASDAQ: JAQC), a Special Purpose Acquisition Company (SPAC) for the creation of a